Home Healthcare IT Global Bone and Joint Health Supplements Market Size, Top Share, Report to 2032

Bone and Joint Health Supplements Market

Bone and Joint Health Supplements Market Size, Share & Trends Analysis Report By Product Type (Calcium, Vitamins, Minerals, Collagen, Omega-3, Glucosamine and Chondroitin, Others), By Form (Capsules, Tablets, Powders, Softgels, Others), By Consumer Group (Infants, Children, Adults, Pregnant Women, Geriatric Population), By Distribution Channel (Pharmacies/Drugstores, Health Food Stores, Supermarkets/Hypermarkets, Online Retail, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI56099DR
Study Period 2020-2032 CAGR 7.25%
Historical Period 2020-2022 Forecast Period 2024-2032
Base Year 2023 Base Year Market Size USD 3.38 billion
Forecast Year 2032 Forecast Year Market Size USD 6.34 billion
Largest Market North America Fastest Growing Market Europe
The sample report only takes 30 secs to download, no need to wait longer.

Market Overview

The global bone and joint health supplements market size was valued at USD 3.38 billion in 2023. It is estimated to reach USD 6.34 billion by 2032, growing at a CAGR of 7.25% during the forecast period (2024–2032).  In recent years, the decline in birth rates and the rise in life expectancy have led to a demographic shift characterized by an increasingly aging population, more susceptible to bone and joint health issues, thereby driving global market growth. Moreover, technological advancements are opening doors to innovative formulations and delivery mechanisms in the bone and joint health supplements market, thereby creating lucrative opportunities for market players. 


  • Capsules dominate the form segment
  • Geriatric population dominates the consumer group segment
  • Supermarkets/hypermarkets dominate the distribution channel segment
  • North America is estimated to be the largest shareholder in the market

Market Overview

Bone and joint health supplements are dietary products formulated to support maintaining and improving bone and joint health. They generally contain vitamins, minerals, and other nutrients crucial for bone density, cartilage function, and overall joint mobility. Common ingredients include calcium, vitamin D, magnesium, glucosamine, chondroitin, and collagen. Calcium strengthens bones, while vitamin D aids in its absorption. Magnesium supports bone density and muscle function. Glucosamine and chondroitin help maintain cartilage integrity, reducing joint pain and inflammation. Collagen offers structural support to joints and may alleviate joint discomfort. These supplements are popular among individuals with joint issues, arthritis, or those looking to safeguard their bone health as they age.

Market Dynamics

Global Bone and Joint Health Supplements Market Drivers

Growing Aging Population

The flourishing aging population is a significant driver propelling the bone and joint health supplements market. The geriatric population is surging in almost every country worldwide. According to the United Nations Report, the worldwide population of 65 and above reached 771 million in 2022, accounting for around 10% of the global population. Projections suggest that it is expected to increase to a rate of 16% by 2050 and is further predicted to rise to 24% by 2100.

With global demographics shifting towards an older population, there's an increased focus on addressing age-related health concerns, including bone density loss and joint ailments. As individuals age, the risk of musculoskeletal disorders such as osteoporosis and arthritis rises, driving demand for supplements that support bone strength and joint mobility. This demographic trend underscores the importance of preventive healthcare measures and proactive management of age-related conditions.

Global Bone and Joint Health Supplements Market Restraint

Limited Regulatory Oversight

Due to limited regulatory oversight, the bone and joint health supplements market faces a significant challenge. Unlike pharmaceutical medicines, dietary supplements are not subject to rigorous pre-market approval by regulatory agencies in many countries. This lack of stringent regulation raises consumer concerns regarding product safety, quality, and efficacy. Without standardized testing and quality control measures, there is a risk of variability in product formulations and potential adulteration with harmful ingredients.

Moreover, misleading claims and exaggerated marketing tactics may mislead consumers about the advantages and risks of these supplements. The absence of clear guidelines and enforcement mechanisms also hinders transparency and accountability within the industry, making it difficult for consumers to make informed purchasing decisions. Thus, such factors are estimated to restrain market growth.

Global Bone and Joint Health Supplements Market Opportunities

Technological Advancements 

Product development using new technologies presents a potential market opportunity for bone and joint health supplements. There is potential to produce supplements that are more consumer-friendly and effective thanks to advancements in formulation and delivery technologies. New ingredients, tailored delivery systems, and improved bioavailability are all made possible by advanced technology, which lets manufacturers create products that satisfy a wide range of consumer demands.

For instance, nanotechnology enables the encapsulation of active ingredients for improved absorption, while sustained-release formulations ensure prolonged efficacy. Moreover, personalized nutrition solutions, incorporating genetic testing and biomarker analysis, enable tailored supplementation based on individual health profiles. Embracing these technological advancements fosters product differentiation and enhances consumer confidence by delivering tangible health benefits, driving growth and competitiveness within the market.

Regional Analysis

Based on region, the global bone and joint health supplements market is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America Dominates the Global Market

North America is the most significant global bone and joint health supplements market shareholder and is expected to expand substantially during the forecast period. North America is dominant in the bone and joint health supplements market, which is attributed to several factors. The region boasts a high prevalence of musculoskeletal disorders, driven by factors such as sedentary lifestyles, obesity, and an aging population. As per the U.S. Department of Health and Human Services, approximately 10 million individuals aged 50 years and above in the United States are affected with osteoporosis. The majority of individuals in this group are women, although approximately 2 million are men. Approximately 43 million additional individuals, including 16 million males, have low bone mass, which increases their susceptibility to osteoporosis.

Furthermore, as per CDC, the age-specific prevalence of osteoporosis, either at the femur neck, lumbar spine, or both, was 12.6% among individuals aged 50 and above. This prevalence was higher among individuals aged 65 and above (17.7%) than those aged 50-64 (8.4%). Moreover, the projected increase in the elderly population in the United States is anticipated to surpass a twofold growth, rising from 53 million individuals in 2018 to 95 million individuals by the year 2060. The proportion of people aged 65 and over is expected to rise from 16.0% to 23.0%. This increasing population is very susceptible to orthopedic disorders and bone abnormalities, contributing to the regional market's rise.

Europe represents a key region in the bone and joint health supplements market, characterized by increasing health consciousness and favorable reimbursement policies. With a soaring aging population and rising prevalence of musculoskeletal disorders, there's a heightened demand for supplements promoting bone density and joint health. For instance, In 2022, Eurostat reported that 21.1% of the people in the European Union were aged 65 or over. Moreover, it is projected that the median age of the EU-27 will rise by 4.5 years between 2019 and 2050, leading to a median age of 48.2 years. This is anticipated to enhance the growth of the regional market.

Furthermore, the prominent players in the region are launching novel products in the market. For instance, in March 2024, Activ'Inside, a French company that focuses on creating active ingredients and formulations for nutritional supplements, has recently launched AiFlex'inside, a supplement specifically developed to promote joint health. This product is designed for both athletes and the older demographic. Consequently, this is estimated to boost the regional market expansion.

Report Scope

Report Metric Details
By Product Type
  1. Calcium
  2. Vitamins
  3. Minerals
  4. Collagen
  5. Omega-3
  6. Glucosamine and Chondroitin
  7. Others
By Form
  1. Capsules
  2. Tablets
  3. Powders
  4. Softgels
  5. Others
By Consumer Group
  1. Infants
  2. Children
  3. Adults
  4. Pregnant Women
  5. Geriatric Population
By Distribution Channel
  1. Pharmacies/Drugstores
  2. Health Food Stores
  3. Supermarkets/Hypermarkets
  4. Online Retail
  5. Others
Company Profiles Herbalife International of America, Inc. GNC Holdings, LLC Nutramax Laboratories Nature's Bounty BYHEALTH Co., Ltd. Amway Pharmavite LLC BASF SE Bayer AG Vitalife Ltd Glanbia plc Reckitt Benckiser Group plc NOW Foods
Geographies Covered
North America U.S. Canada
Europe U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
APAC China Korea Japan India Australia Singapore Taiwan South East Asia Rest of Asia-Pacific
Middle East and Africa UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
LATAM Brazil Mexico Argentina Chile Colombia Rest of LATAM
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Segmental Analysis

The global bone and joint health supplements market is segmented by product type, form, consumer group, and distribution channel.

Based on product type, the global bone and joint health supplements market is segmented into calcium, vitamins, minerals, collagen, omega-3, glucosamine and chondroitin, and others. 

Calcium supplements constitute a significant segment within the bone and joint health supplements market, driven by calcium's crucial role in maintaining skeletal health. These supplements are widely consumed by individuals aiming to stop osteoporosis, a condition characterized by weakened bones and increased fracture risk. Calcium supplements support bone density and strength and aid in muscle function, nerve transmission, and blood clotting. Various formulations of calcium supplements are available, including calcium carbonate, calcium citrate, and calcium phosphate, each with distinct bioavailability and absorption rates.

Moreover, calcium supplements may be combined with other nutrients like vitamin D or magnesium to enhance efficacy. As the aging population surges and awareness of osteoporosis prevention increases, the demand for calcium supplements is expected to rise, presenting lucrative opportunities for market players to innovate and diversify their offerings.

Based on form, the global bone and joint health supplements market is divided into capsules, tablets, powders, softgels, and others. 

The capsules segment dominates the global market. Capsules are one of the most popular bone and joint health supplements, offering convenience, ease of consumption, and precise dosage control. These gelatin or vegetarian-based capsules encase powdered or liquid formulations, ensuring optimal ingredient stability and bioavailability. Consumers prefer capsules for their swallowability and portability, making them suitable for daily supplementation routines.

Moreover, the encapsulation process allows for the inclusion of multiple ingredients, enabling manufacturers to create comprehensive formulas targeting various aspects of bone and joint health. With an increasing emphasis on convenience and on-the-go lifestyles, capsules are a preferred choice among consumers seeking effective and hassle-free solutions for maintaining their musculoskeletal health. This segment is witnessing further growth propelled by advancements in capsule technology, such as enteric coating for improved absorption and sustained-release formulations for prolonged benefits.

Based on consumer groups, the global bone and joint health supplements market is bifurcated into infants, children, adults, pregnant women, and the geriatric population. 

The geriatric population contributed to the largest market share. The geriatric population segment represents a significant bone and joint health supplements market demographic. As individuals age, they are more susceptible to age-related bone and joint issues, such as osteoporosis, osteoarthritis, and joint stiffness. Therefore, the geriatric population often seeks supplements to support bone density, joint flexibility, and overall mobility. These supplements typically contain ingredients like calcium, vitamin D, glucosamine, and chondroitin, which are crucial for maintaining bone strength and joint function.

Moreover, the geriatric population may prefer supplements in easily digestible forms, such as softgels or liquids, making them more accessible for individuals with swallowing difficulties. Manufacturers catering to this segment often provide targeted formulations that address the specific needs and challenges older adults face, promoting independence, mobility, and a better quality of life.

Based on the distribution channel, the global bone and joint health supplements market is bifurcated into pharmacies/drugstores, health food stores, supermarkets/hypermarkets, online retail, and others. 

The supermarkets/hypermarkets segment is estimated to own the highest market share. The supermarkets/hypermarkets segment plays a significant role in the distribution of bone and joint health supplements due to its widespread presence and accessibility to consumers. These retail outlets offer diverse health and wellness products, including supplements, making them convenient shopping destinations for individuals looking to keep their bones and joints healthy. With spacious layouts and well-organized sections, supermarkets and hypermarkets provide ample shelf space for displaying various supplement brands and formulations, enhancing product visibility and consumer choice.

Additionally, these establishments often run promotional campaigns and offer discounts on health products, attracting budget-conscious shoppers. The presence of knowledgeable staff and pharmacists further instills consumer confidence and provides opportunities for personalized recommendations. Overall, supermarkets and hypermarkets serve as key distribution channels for bone and joint health supplements, catering to the needs of a broad demographic of health-conscious consumers.

Market Size By Product Type

Recent Developments

  • April 2024- Borsch Med introduced chondroitin supplements in Singapore to promote joint health.
  • September 2023- Voltaren announced that they are introducing two new products i.e., Comfort & Movement Daily Supplement and Joint Health & Bone Strength Dietary Supplement. These supplements are specifically designed to enhance joint health, improve mobility, and increase flexibility by providing critical nutrients.

Top Key Players

Herbalife International of America, Inc. GNC Holdings, LLC Nutramax Laboratories Nature's Bounty BYHEALTH Co., Ltd. Amway Pharmavite LLC BASF SE Bayer AG Vitalife Ltd Glanbia plc Reckitt Benckiser Group plc NOW Foods Others

Frequently Asked Questions (FAQs)

How big is the bone and joint health supplements market?
The global bone and joint health supplements market size was valued at USD 3.38 billion in 2023. It is estimated to reach USD 6.34 billion by 2032, growing at a CAGR of 7.25% during the forecast period (2024–2032).
North America region has the highest growth rate in the bone and joint health supplements market.
Growing aging population is the major growth factor of the bone and joint health supplements market.
Calcium supplements market sector is expected to dominate over the forecast period.
The key players in the global bone and joint health supplements market include GNC Holdings, LLC, Nutramax Laboratories, Nature's Bounty, BYHEALTH Co., Ltd., Amway, Pharmavite LLC, BASF SE, Bayer AG, Vitalife Ltd, Glanbia plc, NOW Foods.

We are featured on :